Skip to primary navigation Skip to main content
Buffalo Local Index
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
SAGE THERAPEUTIC RG (NQ: SAGE)
169.04 USD  +0.61 (+0.36%)
Official Closing Price  /  Updated: 8:00 PM EDT, Jul 17, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 324,904
Open 168.00
Bid (Size) 167.00 (100)
Ask (Size) 171.00 (300)
Prev. Close 168.43
Today's Range 166.13 - 170.80
52wk Range 59.57 - 195.97
Shares Outstanding 46,515,858
Dividend Yield N/A
Performance
YTD
+1.43%
+1.43%
1 Month
+3.84%
+3.84%
3 Month
+0.13%
+0.13%
6 Month
+0.41%
+0.41%
1 Year
+104.20%
+104.20%
Top News
More News
How We’re Working to Meet the Needs of People Living and Aging With HIV
category UCSD , AIDS , cdc , and 14 more.
from 3BL Media: Corporate Social Responsibility, Energy and Health News
SAGE: Ensuring Dignity and Respect for LGBT Elders
category NYSE:WFC , LGBTQ , Reduced Inequalities , and 6 more.
from 3BL Media: Corporate Social Responsibility, Energy and Health News
More News
Read More
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Sage Therapeutics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
from PR Newswire
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
from Business Wire News Releases
Xcode Life Announces the South Asian Genome (SAGE) Project
category Genetics
from Latest Press Releases from Newswire.com
A pharma CEO says a new depression drug could have lasting effects after one short course, like antibiotics — here's what experts think (SAGE)
category Health, Sage Therapeutics, Drugs, Depression, Pharmaceutical Industry, Pharmaceuticals, Brain, Neuro
from Business Insider
Cramer Remix: Investors can't see the reality of this market
category Energy , Life and Leisure/Entertainment/Gambling , Health Care/Pharmaceuticals Biotechnology and Life Sciences/Biotechnology , and 33 more.
from CNBC.com News
Analysts Anticipate EQAL Will Reach $36
category ETFs
from ETF Channel
Biotech Stock Loses Steam, But Analysts Still Bullish On Depression Drug
from Investor's Business Daily
Sage Therapeutics and Shionogi & Co., Ltd., Enter Strategic Collaboration to Develop and Commercialize SAGE-217 for MDD and Other Indications in Japan, Taiwan and South Korea
from Business Wire News Releases
Sage Therapeutics Earns Relative Strength Rating Upgrade
from Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.